Electrocardiographic Abnormalities and Sudden Death in Myotonic Dystrophy Type 1
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Sudden death can occur as a consequence of cardiac-conduction abnormalities in the neuromuscular disease myotonic dystrophy type 1. The determinants of the risk of sudden death remain imprecise. METHODS: We assessed whether the electrocardiogram (ECG) was useful in predicting sudden death in 406 adult patients with genetically confirmed myotonic dystrophy type 1. A patient was characterized as having a severe abnormality if the ECG had at least one of the following features: rhythm other than sinus, PR interval of 240 msec or more, QRS duration of 120 msec or more, or second-degree or third-degree atrioventricular block. RESULTS: Patients with severe abnormalities according to the entry ECG were older than patients without severe abnormalities, had more severe skeletal-muscle impairment, and were more likely to have heart failure, left ventricular systolic dysfunction, or atrial tachyarrhythmia. Such patients were more likely to receive a pacemaker or an implantable cardioverter-defibrillator during the follow-up period. During a mean follow-up period of 5.7 years, 81 patients died; there were 27 sudden deaths, 32 deaths from progressive neuromuscular respiratory failure, 5 nonsudden deaths from cardiac causes, and 17 deaths from other causes. Among the 17 patients who died suddenly in whom postcollapse rhythm was evaluated, a ventricular tachyarrhythmia was observed in 9. A severe ECG abnormality (relative risk, 3.30; 95% confidence interval [CI], 1.24 to 8.78) and a clinical diagnosis of atrial tachyarrhythmia (relative risk, 5.18; 95% CI, 2.28 to 11.77) were independent risk factors for sudden death. CONCLUSIONS: Patients with adult myotonic dystrophy type 1 are at high risk for arrhythmias and sudden death. A severe abnormality on the ECG and a diagnosis of an atrial tachyarrhythmia predict sudden death. (ClinicalTrials.gov number, NCT00622453.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989) · New England Journal of Medicine · doi:10.1056/nejm198908103210629 · Cited by 3,300
Brook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A. J., Church, D., Aburatani, H., Hunter, K., Stanton, V. P., Thirion, J.-P., Hudson, T., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90154-5 · Cited by 2,777
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
An Unstable Triplet Repeat in a Gene Related to Myotonic Muscular Dystrophy
Fu, Y. H., Pizzuti, A., Fenwick, R. G., King, J., Rajnarayan, S., Dunne, P. W., Dubel, J., Nasser, G. A., Ashizawa, T., de Jong, P., et al. (1992) · Science · doi:10.1126/science.1546326 · Cited by 1,455
Gregoratos, G., Abrams, J., Epstein, A. E., Freedman, R. A., Hayes, D. L., Hlatky, M. A., Kerber, R. E., Naccarelli, G. V., Schoenfeld, M. H., Silka, M. J., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02528-7 · Cited by 1,266
Committee Members, Gregoratos, G., Abrams, J., Epstein, A. E., Freedman, R. A., Hayes, D. L., Hlatky, M. A., Kerber, R. E., Naccarelli, G. V., Schoenfeld, M. H., et al. (2002) · Circulation · doi:10.1161/01.cir.0000035996.46455.09 · Cited by 910
Chugh, S. S., Jui, J., Gunson, K., Stecker, E. C., John, B. T., Thompson, B., Ilias, N., Vickers, C., Dogra, V., Daya, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.06.029 · Cited by 795
Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy
Buxton, J., Shelbourne, P., Davies, J., Jones, C., Tongeren, T. V., Aslanidis, C., de Jong, P., Jansen, G., Anvret, M., Riley, B., et al. (1992) · Nature · doi:10.1038/355547a0 · Cited by 620
Cloning of the essential myotonic dystrophy region and mapping of the putative defect
Aslanidis, C., Jansen, G., Amemiya, C., Shutler, G., Mahadevan, M., Tsilfidis, C., Chen, C., Alleman, J., Wormskamp, N. G. M., Vooijs, M., et al. (1992) · Nature · doi:10.1038/355548a0 · Cited by 498
A 10-year study of mortality in a cohort of patients with myotonic dystrophy
Mathieu, J., Allard, P., Potvin, L., Prévost, C., & Bégin, P. (1999) · Neurology · doi:10.1212/wnl.52.8.1658 · Cited by 414
Research works printed but not linked: 2
- Florek RC, 1990, West J Med, 153, 24
- 10.1001/jama.271.11.840 · DOI · Paper page
Cited by
Items 201–300 of 511
Shah, M. J., Silka, M. J., Silva, J. N. A., Balaji, S., Beach, C. M., Benjamin, M. N., Berul, C. I., Cannon, B. C., Cecchin, F., Cohen, M. I., et al. (2021) · Indian Pacing and Electrophysiology Journal · doi:10.1016/j.ipej.2021.07.005 · Cited by 19
“87,92 In a meta-analysis, arrhythmias were observed in 36% of patients before 20 years of age, with heart failure observed in 10% before 30 years of age.”
Prolonged Corrected QT Interval in Patients with Myotonic Dystrophy Type 1
Park, K. M., Shin, K. J., Kim, S. E., Park, J., Ha, S. Y., & Kim, B. J. (2013) · Journal of Clinical Neurology · doi:10.3988/jcn.2013.9.3.186 · Cited by 16
Kalra, S., Montanaro, F., & Denning, C. N. (2016) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-150133 · Cited by 18
“Echocardiographic abnormalities include mitral valve prolapse, systolic and diastolic function impairment, and reduction in ejection fraction [130].”
BackgroundChou, C., Chang, P., Wei, Y., & Lee, K. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005191 · Cited by 21
Interatrial block to predict atrial fibrillation in myotonic dystrophy type 1
Russo, V., Papa, A. A., Rago, A., Ciardiello, C., Marano, M., Proietti, R., Politano, L., & Nigro, G. (2018) · Neuromuscular Disorders · doi:10.1016/j.nmd.2018.01.010 · Cited by 16
Myotonic Dystrophy Type 2 – Data from the Serbian Registry
Božović, I., Perić, S., Pešović, J., Bjelica, B., Brkušanin, M., Basta, I. Z., Bozic, M. M., Senćanić, I., Marjanović, A., Branković, M., et al. (2018) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-180328 · Cited by 16
“Severe ECG abnormality was defined according to Groh’s definition given for DM1 patients: rhythm other than sinus, PR interval of 240 ms or more, QRS duration of 120 ms or more, second degree or third-degree AV block [10].”
Cardiac magnetic resonance in patients with muscular dystrophies
Grigoratos, C., Aimo, A., Barison, A., Castiglione, V., Todiere, G., Ricci, G., Siciliano, G., & Emdin, M. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487320923052 · Cited by 16
Petri, H., Mohammad, B. J. Y., Kristensen, A. T., Thune, J. J., Vissing, J., Køber, L., Witting, N., Bundgaard, H., & Christensen, A. H. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.132070 · Cited by 15
Facenda-Lorenzo, M., Hernández-Afonso, J. S., Rodríguez-Esteban, M., de León-Hernández, J. C., & Grillo-Pérez, J. J. (2012) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2012.08.011 · Cited by 15
“El seguimiento medio fue de 5,7 3,9 (1-20) años y se documentó bradicardia sinusal en el 48,8%, disfunción sinusal en el 13,8%, arritmias supraventriculares en el 10%, intervalo PR 220 ms en el 31,3%, taquicardia ventricular el 5%, intervalo QT corregido largo en el 5%, bloqueo auriculoventricular de segundo o tercer…”
BackgroundTurner, C., Hilton‐Jones, D., Lochmüller, H., & Hanna, M. G. (2013) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.07.006 · Cited by 15
“[12] and Wahbi et al.”
BackgroundTurillazzi, E., Neri, M., Riezzo, I., Paolo, M. D., Evangelisti, L., & Fineschi, V. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.07.135 · Cited by 15
“The central question still remains the determinants of the risk of SD in DM1 patients since the usefulness of ECG remains unknown [6].”
BackgroundBosè, F., Renna, L. V., Fossati, B., Arpa, G., Labate, V., Milani, V., Botta, A., Micaglio, E., Meola, G., & Cardani, R. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00992 · Cited by 15
“Cardiac defects affect 80% of individuals with DM1 and represent the second most common cause of death (17, 18).”
BackgroundExcessive daytime sleepiness in myotonic dystrophy: a narrative review
Hoxhaj, D., Pascazio, A., Maestri, M., Ricci, G., Fabbrini, M., Torresi, F. B., Siciliano, G., & Bonanni, E. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1389949 · Cited by 14
Variability of multisystemic features in myotonic dystrophy type 1 – lessons from Serbian registry
Rakočević-Stojanović, V., Perić, S., Basta, I. Z., Dobričić, V. S., Ralić, V., Kačar, A., Perić, M., & Novaković, I. V. (2015) · Neurological Research · doi:10.1179/1743132815y.0000000068 · Cited by 14
Auxerre-Plantié, E., Nakamori, M., Renaud, Y., Huguet-Lachon, A., Choquet, C., Dondi, C., Miquerol, L., Takahashi, M. P., Gourdon, G., Junion, G., et al. (2019) · eLife · doi:10.7554/elife.51114 · Cited by 14
Autonomic predictors of recovery following surgery: A comparative study
Williamson, J. B., Lewis, G., Grippo, A. J., Lamb, D., Harden, E., Handleman, M., Lebow, J., Carter, C. S., & Porges, S. W. (2010) · Autonomic Neuroscience · doi:10.1016/j.autneu.2010.03.009 · Cited by 14
“Due to its strong neurophysiological basis, RSA has been a primary focus of research applying HRV to clinical conditions (e.g., obesity, (Tonhajzerova et al., 2008), sudden death, (Groh et al., 2008), irritable bowel syndrome, (Spetalen et al., 2008)).”
Sudden Death in Myotonic Dystrophy
Russo, A. D., Pace, M., & Bellocci, F. (2008) · New England Journal of Medicine · doi:10.1056/nejmc081492 · Cited by 14
Russo, V., Papa, A. A., Rago, A., Ciardiello, C., Martino, A. M., Stazi, A., Golino, P., Calò, L., & Nigro, G. (2021) · EP Europace · doi:10.1093/europace/euab282 · Cited by 15
Nguyen, C. É., & Campbell, C. (2016) · Canadian Medical Association Journal · doi:10.1503/cmaj.151384 · Cited by 13
Russo, V., Papa, A. A., Rago, A., Ciardiello, C., & Nigro, G. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2018.03.008 · Cited by 13
Myotonic disorders and pregnancy
Morton, A. (2019) · Obstetric Medicine · doi:10.1177/1753495x18824238 · Cited by 13
“Approximately 15% of patients with DM1 and DM2 have left ventricular dysfunction on echocardiography, and 24% have rhythm disturbances due to conduction system fibrosis.(12,13) The effect of pregnancy on cardiac disease in DM is not known.”
BackgroundBłaszczyk, E., Lim, C., Kellman, P., Schmacht, L. M., Gröschel, J., Spuler, S., & Schulz‐Menger, J. (2021) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-021-00812-6 · Cited by 13
Management of cardiac involvement in muscular dystrophies: paediatric versus adult forms.
Palladino, A., D′Ambrosio, P., Papa, A. A., Petillo, R., Orsini, C., Scutifero, M., Nigro, G., & Politano, L. (2016) · PubMed Central · Cited by 17
Nikhanj, A., Sivakumaran, S. T., Yogasundaram, H., Becher, H. H., Kimber, S., Siddiqi, Z. A., & Oudit, G. Y. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.08.039 · Cited by 13
Tylock, K. M., Auerbach, D. S., Tang, Z. Z., Thornton, C. A., & Dirksen, R. T. (2020) · The Journal of General Physiology · doi:10.1085/jgp.201912450 · Cited by 16
“an increased incidence of premature death, due in part to sudden cardiac death (SCD; de Die-Smulders et al., 1998; Mathieu et al., 1999; Groh et al., 2008; Chong-Nguyen et al., 2017), even in patients with pacemakers (Laurent et al.”
BackgroundNoninvasive Home Mechanical Ventilation in Adult Myotonic Dystrophy Type 1: A Systematic Review
Vosse, B. A. H., Seijger, C., Cobben, N. A. M., van Engelen, B. G. M., van Kuijk, S. M. J., Faber, C. G., & Wijkstra, P. J. (2021) · Respiration · doi:10.1159/000515453 · Cited by 13
Brugada‐like cardiac disease in myotonic dystrophy type 2: report of two unrelated patients
Rudnik‐Schöneborn, S., Schaupp, M., Lindner, A., Kress, W., Schulze‐Bahr, E., Zumhagen, S., Elbracht, M., & Zerres, K. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03077.x · Cited by 13
“In DM1, atrial tachyarrhythmia was the most common finding in 26 of 96 patients with severe ECG abnormalities while ventricular tachyarrhythmia was seen in four patients only [2].”
BackgroundArrhythmia exacerbation after sodium channel blockade in myotonic dystrophy type 1
Otten, R. F., Scherschel, J. A., Lopshire, J. C., Bhakta, D., Pascuzzi, R. M., & Groh, W. J. (2009) · Muscle & Nerve · doi:10.1002/mus.21345 · Cited by 13
Self-citationNguyen, C., Jimenez‐Moreno, C., Merker, M., Bowers, C. J., Nikolenko, N., Hentschel, A., Müntefering, T., Isham, A., Ruck, T., Vorgerd, M., et al. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11633-1 · Cited by 13
“Previously, age, disease duration, gender (male), CTG-expansion length and plasma levels of Troponin-I have been associated with cardiac disease severity and progression of disease in DM1 [1, 4, 8, 9].”
BackgroundExpert opinion on mexiletine treatment in adult patients with myotonic dystrophy
Wahbi, K., Bassez, G., Duchâteau, J., Salort‐Campana, E., Vicart, S., Desaphy, J., Labombarda, F., Sellal, J., & Deharo, J. (2024) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2024.03.001 · Cited by 12
Genetic spectrum of cardiomyopathies with neuromuscular phenotype
Kostareva, A. A. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s375 · Cited by 12
“There is no clear evidence that the severity of cardiac abnormalities correlate with the number of the repeats and several studies showed conflicting results on this association (70-73).”
BackgroundResultInfluentialGender effect on cardiac involvement in myotonic dystrophy type 1
Garibaldi, M., Lauletta, A., Bucci, E., Fionda, L., Vanoli, F., Leonardi, L., Alfieri, G., Tufano, L., Morino, S., Merlonghi, G., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14665 · Cited by 14
Myotonic dystrophy type 1: A comparison between the adult‐ and late‐onset subtype
Joosten, I. B. T., Horlings, C. G. C., Vosse, B. A. H., Wagner, A., Bovenkerk, D., Evertz, R., Vernooy, K., van Engelen, B. G. M., & Faber, C. G. (2022) · Muscle & Nerve · doi:10.1002/mus.27766 · Cited by 14
“Age of onset (years), median [IQR] 27 [16-38] 25 [16-34] 50 [42-52] <.”
Neurología y cardiología: puntos de contacto
Goldstein, L. B., & Husseini, N. E. (2011) · Revista Española de Cardiología · doi:10.1016/j.recesp.2010.12.004 · Cited by 15
Survival patterns and cancer determinants in families with myotonic dystrophy type 1
Best, A. F., Hilbert, J. E., Wood, L., Martens, W. B., Nikolenko, N., Marini‐Bettolo, C., Lochmüller, H., Rosenberg, P. S., Moxley, R., Greene, M. H., et al. (2018) · European Journal of Neurology · doi:10.1111/ene.13763 · Cited by 12
“Also, the high risk of sudden death noted in patients with DM1 [19] has recently been shown to be associated with a family history of sudden death [20].”
BackgroundSiméon, E., Patier-Dussauge, A., Bernard-Brunet, A., Clémenty, N., Gouraud, J.-B., Guyomarch, B., Magot, A., Probst, V., & Babuty, D. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.02.001 · Cited by 12
Bienias, P., Łusakowska, A., Ciurzyński, M., Rymarczyk, Z., Irzyk, K., Kurnicka, K., Kamińska, A., & Pruszczyk, P. (2016) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12924 · Cited by 12
Clémenty, N., Labombarda, F., Grolleau, F., Algalarrondo, V., Bassez, G., Bécane, H. M., Béhin, A., Chapon, F., Hachmi, M. E., Fayssoil, A., et al. (2025) · JAMA Cardiology · doi:10.1001/jamacardio.2025.3055 · Cited by 12
Wong, J. A., Roberts, J. D., & Healey, J. S. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.01.024 · Cited by 11
Ventricular Tachycardia in a Patient with Inclusion‐Body Myositis
Prutkin, J. M., & Patton, K. K. (2009) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2009.02534.x · Cited by 11
Atrioventricular Conduction System Disease
Vijayaraman, P., & Ellenbogen, K. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-37804-8.00014-6 · Cited by 13
Modeling of Myotonic Dystrophy Cardiac Phenotypes in Drosophila
Chakraborty, M., Llamusí, B., & Artero, R. D. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00473 · Cited by 11
“This are affecting 40% of the DM1 patients (34) and 65% patients have an abnormal ECG.”
BackgroundDewald, Z., Adesanya, O. A., Bae, H., Gupta, A. S., Derham, J. M., Chembazhi, U. V., & Kalsotra, A. (2024) · Nature Communications · doi:10.1038/s41467-024-53378-z · Cited by 13
“In the case of a few anesthetics, the patient may require intervention to prevent death 20,45 .”
BackgroundValaperta, R., Lombardi, F., Cardani, R., Fossati, B., Brigonzi, E., Merli, I., Sansone, V., Merletti, G., Spina, E., Meola, G., et al. (2015) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2015.0135 · Cited by 10
“The ECG abnormalities were considered severe if PR interval ‡ 240 ms, QRS duration ‡ 120 ms (Groh et al. , 2008).”
Increased heterogeneity of ventricular repolarization in myotonic dystrophy type 1 population.
Russo, R., Papa, A. A., Rago, A., D′Ambrosio, P., Cimmino, G., Palladino, A., Politano, L., & Nigro, G. (2016) · PubMed Central · Cited by 10
Gutiérrez‐Gutiérrez, G., Díaz‐Manera, J., Almendrote, M., Azriel, S., Bárcena, J. E., Cabezudo‐García, P., Camacho, A., Rodríguez, C. C., Cobo, A. M., Guardiola, P. D., et al. (2019) · Medicina Clínica · doi:10.1016/j.medcli.2018.10.028 · Cited by 61
Nikhanj, A., Nichols, B. M., Wang, K., Siddiqi, Z. A., & Oudit, G. Y. (2020) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcaa059 · Cited by 10
Myocardial and Arrhythmic Spectrum of Neuromuscular Disorders in Children
Baban, A., Lodato, V., Parlapiano, G., Mambro, C. D., Adorisio, R., Bertini, E., Dionisi‐Vici, C., Drago, F., & Martinelli, D. (2021) · Biomolecules · doi:10.3390/biom11111578 · Cited by 10
Unmasked Brugada Pattern by Ajmaline Challenge in Patients with Myotonic Dystrophy Type 1
Pambrun, T., Bortone, A. A., Bois, P., Degand, B., Patri, S., Mercier, A., Chahine, M., Chatelier, A., Coisne, D., & AMIEL, A. (2014) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12168 · Cited by 10
“Methods: Among 36 adult DM1 patients referred to our institution, electrophysiological study and ajmaline challenge were performed in 12 patients fulfilling the following criteria: (1) PR interval >200 ms or QRS duration >100 ms; (2) absence of complete left bundle branch block; (3) absence of permanent ventricular pa…”
BackgroundMethodVariabilidade da frequência cardíaca em pacientes com Distrofia Miotônica tipo 1
Fregonezi, G., Araujo, T. L., Júnior, M. E. T. D., de Sá, J. C. F., da Silva, E., & Resqueti, V. (2012) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2012005000021 · Cited by 10
Implantable loop recorders in myotonic dystrophy 1
Stöllberger, C., Steger, C. M., Gabriel, P., & Finsterer, J. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.07.085 · Cited by 10
“Electrocardiographic and echocardiographic risk markers for SCD in MD1 have been identified: a rhythm other than sinus rhythm, PR interval≥240 ms, QRS duration ≥120 ms, second-degree or third-degree atrioventricular block, an increased QTc interval, atrial tachyarrhythmia and systolic dysfunction [2,3,12,14].”
BackgroundValaperta, R., Siena, C. D., Cardani, R., Lombardia, F., Cenko, E., Rampoldi, B., Fossati, B., Brigonzi, E., Rigolini, R., Gaia, P., et al. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.10.020 · Cited by 10
Papa, A. A., Verrillo, F., Scutifero, M., Rago, A., Morra, S., Cassese, A., Cioppa, N. D., Magliocca, M. C. G., Galante, D., Palladino, A., et al. (2018) · Europe PMC (PubMed Central) · Cited by 10
An evaluation of 24 h Holter monitoring in patients with myotonic dystrophy type 1
Joosten, I. B. T., Janssen, C. E. W., Horlings, C. G. C., den Uijl, D. W., Evertz, R., van Engelen, B. G. M., Faber, C. G., & Vernooy, K. (2022) · EP Europace · doi:10.1093/europace/euac104 · Cited by 9
“Conduction abnormalities such as AV blocks and bundle branch blocks are observed in 17–45% of patients, while atrial fibrillation/ flutter and ventricular arrhythmias are described to be present in, respectively, 5–13 and 1–4% of the DM1 population.(1,13,14) In the current study, ECG abnormalities were present in 43%…”
BackgroundSochala, M., Wahbi, K., Sorbets, E., Lazarus, A., Bécane, H.-M., Stojkovic, T., Fayssoil, A., Laforêt, P., Béhin, A., Sroussi, M., et al. (2017) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-170232 · Cited by 9
“The prevention of sudden death (SD), affecting up to 1/3 of patients, is central in the management of this disorder [5, 6].”
Expression of expanded GGC repeats within NOTCH2NLC causes cardiac dysfunction in mouse models
Pan, Y., Jiang, Y., Wan, J., Hu, Z., Jiang, H. F., Shen, L. H., Tang, B., Tian, Y., & Liu, Q. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01111-6 · Cited by 10
Vosse, B. A. H., Horlings, C. G. C., Joosten, I. B. T., Cobben, N. A. M., van Kuijk, S. M. J., Wijkstra, P. J., & Faber, C. G. (2023) · Neuromuscular Disorders · doi:10.1016/j.nmd.2023.08.004 · Cited by 9
“[4] Groh WJ, Groh MR, Saha C, Kincaid JC, Simmons Z, Ciafaloni E, et al.”
BackgroundGarcia, R., Labarre, Q., Degand, B., Ingrand, P., Gal, F. L., Bonnet, B., Delaubier, A., Guillou, C. L., Gellen, B., Coisne, D., et al. (2017) · Echocardiography · doi:10.1111/echo.13426 · Cited by 9
Routine echocardiography in patients with myotonic dystrophy type 1
Paunic, T., Perić, S., Cvitan, E., Raspopović, S., Perić, M., Stojmenović, G. M., & Stojanović, V. R. (2017) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2017.04.004 · Cited by 9
Kaminsky, P., & Pruna, L. (2012) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2012.03.355 · Cited by 8
MBNL overexpression rescues cardiac phenotypes in a myotonic dystrophy type 1 heart mouse model
Hu, R.-C., Zhang, Y., Nitschke, L., Johnson, S. J., Hurley, A. E., Lagor, W. R., Xia, Z., & Cooper, T. A. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186416 · Cited by 12
Fonction musculaire et atteinte d’organes dans la dystrophie myotonique de type 1
Pruna, L., Machado, F., Louis, L., Vassé, G., & Kaminsky, P. (2010) · Revue Neurologique · doi:10.1016/j.neurol.2010.07.026 · Cited by 8
Lee, J., Thornhill, R. E., Nery, P. B., deKemp, R. A., Peña, E., Birnie, D. H., Adler, A., & Ukwatta, E. (2019) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2019.103341 · Cited by 9
Mazzoli, M., Ariatti, A., Garuti, G., Agnoletto, V., Genovese, M., Gozzi, M., Kaleci, S., Marchioni, A., Malagoli, M., & Galassi, G. (2020) · PubMed Central · doi:10.36185/2532-1900-015 · Cited by 14
Cardiac Involvement and Arrhythmias Associated with Myotonic Dystrophy
McBride, D., Deshmukh, A., Shore, S., Elafros, M. A., & Liang, J. J. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2304126 · Cited by 8
“Atrial arrhythmias are the most common clinical arrhythmias associated with DM1 and represent an independent predictor of increased mortality [35].”
BackgroundInfluentialSp, G., Kostyukevich, M. V., Laiovich, L. I., Mironov, N. Y., Миронова, Н. А., Utsumueva, M. D., Khusyainova, D. R., Шлевков, Н. Б., Bazarov, B. C., Азизов, В. А., et al. (2022) · Eurasian heart journal · doi:10.38109/2225-1685-2022-4-6-67 · Cited by 14
Russo, V., Capolongo, A., Bottino, R., Carbone, A., Palladino, A., Liccardo, B., Nigro, G., Marchel, M., Golino, P., & D’Andrea, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12051947 · Cited by 8
Bachmann bundle pacing reduces atrial electromechanical delay in type 1 myotonic dystrophy patients
Russo, V., Rago, A., Papa, A. A., Arena, G., Politano, L., & Nigro, G. (2018) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-018-0331-5 · Cited by 8
“Several studies have associated baseline electrocardiographic abnormalities with the risk of sudden death in DM1 patients [2].”
BackgroundGinjupalli, V. K. M., Reisqs, J., Cupelli, M., Chahine, M., & Boutjdir, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262210992 · Cited by 8
“Even asymptomatic DM1 individuals often exhibit prolonged QRS and PR intervals [15].”
InfluentialAn overview of heart rhythm disorders and management in myotonic dystrophy type 1
Gossios, T. D., Providencia, R. A., Creta, A., Segal, O. R., Nikolenko, N., Turner, C., Lopes, L. R., Wahbi, K., & Savvatis, K. (2021) · Heart Rhythm · doi:10.1016/j.hrthm.2021.11.028 · Cited by 7
Limpitikul, W. B., Ong, C. S., & Tomaselli, G. F. (2017) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2017.07.013 · Cited by 9
Diastolic heart dysfunction is correlated with CTG repeat length in myotonic dystrophy type 1
Park, J., Kim, N., & Park, D. (2018) · Neurological Sciences · doi:10.1007/s10072-018-3530-z · Cited by 7
Koehorst, E., Odria, R., Capó, J., Núñez‐Manchón, J., Arbex, A., Almendrote, M., Linares‐Pardo, I., Benito, D. N., Saez, V., Nascimento, A., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10061372 · Cited by 8
Elstein, D., Ioscovich, A., Eldar‐Geva, T., Weitman, M., Altarescu, G., & Rivilis, A. (2013) · Journal of Human Reproductive Sciences · doi:10.4103/0974-1208.126303 · Cited by 7
Panaite, P., Küntzer, T., Gourdon, G., & Barakat, I. (2013) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2013.06.014 · Cited by 7
Deregulation of RNA Metabolism in Microsatellite Expansion Diseases
Misra, C., Lin, F., & Kalsotra, A. (2018) · Advances in neurobiology · doi:10.1007/978-3-319-89689-2_8 · Cited by 7
Schmid, J., Beer, M., Berghold, A., Stojaković, T., Scharnagl, H., Dieplinger, B., Quasthoff, S., Binder, J. S., & Rainer, P. P. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12763 · Cited by 7
“where the biggest concern is an increased risk of sudden cardiac death, which has been linked to severe ECG abnormalities.(17) Although ECG findings were unremarkable in many patients using established cut-offs, depolarization (QRS time and BBB) and repolarization (QTc interval) were significantly longer than in healt…”
BackgroundHereditary muscle diseases and the heart: the cardiologist’s perspective
Giuliani, L., Toro, A. D., Urtis, M., Smirnova, A., Concardi, M., Favalli, V., Serio, A., Grasso, M., & Arbustini, E. (2020) · European Heart Journal Supplements · doi:10.1093/eurheartj/suaa051 · Cited by 8
Cardiac involvement in myotonic dystrophy
Khalighi, K., Kodali, A., Thapamagar, S. B., & Walker, S. R. (2015) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.3402/jchimp.v5.25319 · Cited by 7
“Severe conduction system abnormalities are defined as: any rhythm other than sinus, a PR interval more than 240 ms, a QRS duration over 120 ms, or a second- or thirddegree AV block; and all are independent risk factors of sudden death (8).”
BackgroundDuboc, D., & Wahbi, K. (2012) · Heart · doi:10.1136/heartjnl-2011-301407 · Cited by 7
Rhythm management in myotonic dystrophy: Progress has been made, but unsettled issues remain
Groh, W. J. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2018.03.037 · Cited by 7
Self-citationHata, Y., Ichimata, S., Yoshida, K., Yamaguchi, Y., Hirono, K., & Nishida, N. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11850-8 · Cited by 7
“…AV conduction delay, non-specific intra-ventricular conduction delay, left-or right-bundle branch block, pathologic q-wave, and repolarization abnormalities, have been associated with DM1 and may be caused by interstitial fibrosis of the myocardium, including the conduction system [12, 26].”
Influential2025 Clinical practice guidelines for Bradyarrhythmias and conduction disorders
Revishvili, A. S. H., Glezer, M. G., Artyukhina, Е. А., Базаев, В. А., Batalov, R. E., Bockeria, L. A., Davtyan, K. V., Lebedev, D. S., Лебедева, В. К., Lyubimtseva, T. A., et al. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6669 · Cited by 8
Conte, E., Ware, K., Marvulli, R., Ianieri, G., Megna, M., Conte, S., Mendolicchio, L., & Pierangeli, E. (2015) · World Journal of Cardiovascular Diseases · doi:10.4236/wjcd.2015.56017 · Cited by 6
Structural myocardial involvement in adult patients with type 1 myotonic dystrophy
Dhand, U. K., Raja, F., & Aggarwal, K. B. (2013) · Neurology International · doi:10.4081/ni.2013.e5 · Cited by 6
Pacing for Atrioventricular Conduction System Disease
Stambler, B. S., & Ellenbogen, K. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1616-0.00014-x · Cited by 6
New developments in myotonic dystrophies from a multisystemic perspective
Montagnese, F., & Schoser, B. G. H. (2021) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000964 · Cited by 7
Systemic Diseases and Heart Block
Sabzwari, S. R. A., & Tzou, W. S. (2021) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2021.06.011 · Cited by 7
Wan, Q., Wang, Y., Yong, M., Hu, P., Liang, C. G. L., Xiang, Y., Zhao, X. Y., San, D., Bai, T. T., Tong, L.-G., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114103 · Cited by 6
Stöllberger, C., Keller, H., Steger, C. M., & Finsterer, J. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.05.082 · Cited by 6
“Since myotonic dystrophy type 1 is frequently associated with brady- and tachyarrhythmias, an ILR (Reveal XT, Medtronic, Inc) was implanted [7].”
BackgroundNeurology and Cardiology: Points of Contact
Goldstein, L. B., & Husseini, N. E. (2011) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2010.12.010 · Cited by 8
Russo, V., Papa, A. A., & Nigro, G. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.0927 · Cited by 6
The prevalence of electrocardiogram abnormalities in professional divers
Güneş, A. E., & Çimşit, M. (2017) · Diving and Hyperbaric Medicine Journal · doi:10.28920/dhm47.1.55-58 · Cited by 8
Nitschke, L., Hu, R.-C., Miller, A. N., & Cooper, T. A. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae117 · Cited by 5
Gender disparities in myotonic dystrophy 1
Chakraborty, D., Borthakur, S., Sarkar, R., & Singh, M. D. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123659 · Cited by 5
Myotone Dystrophien, nicht dystrophe Myotonien und periodische Paralysen
Schneider‐Gold, C., Schoser, B. G. H., Ellrichmann, G., Quasthoff, S., Lehmann‐Horn, F., & Sinnreich, M. (2018) · Aktuelle Neurologie · doi:10.1055/s-0043-125352 · Cited by 5
Russo, V., Antonini, G., Massa, R., Casali, C., Mauriello, A., Martino, A. M., Marconi, R., Garibaldi, M., Franciosa, P., Zecchin, M., et al. (2024) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd11020063 · Cited by 11
“…of atrial tachyarrhythmia and electrocardiogram (ECG) with one of the following features: any rhythm other than sinus rhythm, PR interval ≥ 240 ms, QRS duration ≥ 120 ms, second-or third-degree atrioventricular block [37,39], age, family history of SCD, and left bundle branch block [40,41].”
BackgroundInfluentialCTG repeat length underlying cardiac events and sudden death in myotonic dystrophy type 1
Itoh, H., Hisamatsu, T., Segawa, K., Takahashi, T., Sato, T., Takada, H., Kuru, S., Wada, C., Suzuki, M., Tamura, T., et al. (2024) · European Heart Journal Open · doi:10.1093/ehjopen/oeae078 · Cited by 5
Abati, E., Alberti, C., Tambè, V., Esseridou, A., Comi, G. P., Corti, S. P., Meola, G., & Secchi, F. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1493570 · Cited by 5
Werlauff, U., Rudolfsen, J. H., Andersen, H., Vissing, J., Rossau, C. D., Dreyer, P., Olsen, J., Bengtsson, S., Aagaard, H., & Handberg, C. (2025) · European Journal of Neurology · doi:10.1111/ene.70135 · Cited by 5
Metadata
- Authors
- Groh, W. J., Groh, M. R., Saha, C., Kincaid, J. C., Simmons, Z., Ciafaloni, E., Pourmand, R., Otten, R. F., Bhakta, D., Nair, G. V., Marashdeh, M. M., Zipes, D. P., & Pascuzzi, R. M.
- Affiliations
- Indiana University Indianapolis (US)
- Pennsylvania State University (US)
- University of Rochester Medicine (US)
- State University of New York (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-06-19
- Volume
- 358
- Issue
- 25
- Pages
- 2688-2697
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2083028245
- Cited by
- 511
- References
- 32
- Citations by year
- 2026: 19 · 2025: 21 · 2024: 19 · 2023: 22 · 2022: 26 · 2021: 30 · 2020: 34 · 2019: 31 · 2018: 36 · 2017: 39 · 2016: 34 · 2015: 28 · 2014: 32 · 2013: 20 · 2012: 32
- FWCI
- 20.88
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Center for Research Resources (MO1 RR00750-27S1, M01RR000750)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Keywords
- myotonic dystrophy type 1, sudden death, electrocardiographic abnormalities, atrial tachyarrhythmia, ventricular tachyarrhythmia, cardiac conduction disorders, atrioventricular block, risk factors, implantable cardioverter-defibrillator, cardiac pacemaker, neuromuscular disorders
- MeSH terms
- Adult, Arrhythmias, Cardiac, Cause of Death, Electrocardiography, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myotonic Dystrophy, Prognosis, Risk Factors, Tachycardia, Death, Sudden, Cardiac
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.